Neonatal complications following in utero paroxetine exposure

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2003年 / 935-936卷 / 1期

关键词：

Public Health; Cohort Study; Pregnant Woman; Constipation; Respiratory Distress;

D O I：

10.2165/00128415-200309350-00008

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：4 / 4

相关论文

共 50 条

[1] Lack of birth defects following in utero paroxetine exposure
Reactions Weekly, 2006, 1108 (1) : 3 - 3
[2] CitalopramPoor neonatal adaptation syndrome following in utero exposure: case report
Reactions Weekly, 2012, 1385 (1) : 15 - 15
[3] Atenolol/valsartanPregnancy complications leading to fetal death following in utero exposure: case report
Reactions Weekly, 2001, 880 (1) : 7 - 7
[4] MethadoneThrombocytosis following in utero exposure: case report
Reactions Weekly, 2011, 1355 (1) : 23 - 23
[5] IsotretinoinTeratogenesis following in utero exposure?: case report
Reactions Weekly, 2010, 1285 (1) : 20 - 20
[6] ValsartanOliguria following in utero exposure: case report
Reactions Weekly, 2007, 1161 (1) : 22 - 22
[7] OlanzapineLack of adverse effects in a neonate following in utero exposure: case report
Reactions Weekly, 2000, 800 (1) : 11 - 12
[8] Triazolam overdoseRespiratory depression in a neonate following in utero exposure: case report
Reactions Weekly, 1997, 644 (1) : 12 - 12
[9] WarfarinBrachytelephalangic chondrodysplasia punctata in an neonate following in utero exposure: case report
Reactions Weekly, 2010, 1313 (1) : 42 - 42
[10] The frequency of neonatal morbidity after exposure to antiepileptic drugs in utero
Burja, Silva
Rakovec-Felser, Zlatka
Treiber, Milena
Hajdinjak, Dusanka
Gajsek-Marchetti, Marijana
WIENER KLINISCHE WOCHENSCHRIFT, 2006, 118 (9-10) : 12 - 16

← 1 2 3 4 5 →